info@seagull-health.com
SeagullHealth
语言:
search
new
Storage of Carbachol and Brimonidine Tartrate Ophthalmic Solution (Yuvezzi)
512
Article source: Seagull Pharmacy
Jun 23, 2026

Proper storage of carbachol and brimonidine tartrate ophthalmic solution (Yuvezzi) is an important prerequisite for ensuring stability of efficacy and guaranteeing safe medication use.

I. Appropriate Storage Environment

1. Temperature Control

(1) Unopened medicinal products should be stored at room temperature between 36°F and 77°F (i.e., 2°C to 25°C).

(2) Avoid placing in excessively hot environments (e.g., enclosed cars in summer, near heating vents) or excessively cold environments (e.g., freezer compartment of a refrigerator).

(3) Excessive heat may accelerate degradation of active ingredients, while excessive cold may cause crystallization or osmotic pressure changes, affecting efficacy and ocular comfort.

2. Protection from Light

(1) The solution is green-yellow in color and sensitive to light.

(2) Unused single-dose vials must be kept in the original aluminum foil pouch until immediately before use.

(3) The aluminum foil pouch effectively blocks light and prevents photodegradation.

(4) Do not remove single-dose vials in advance and place them in transparent pill organizers or on bright countertops for prolonged exposure, as this may cause deterioration of the solution.

3. Dryness and Sealing

(1) The entire carton should be stored in a cool, dry place, away from humid areas such as bathrooms or near kitchen sinks.

(2) Moisture may penetrate the packaging, compromising the seal of the aluminum foil pouch or causing labels to become illegible. At the same time, avoid heavy pressure or crushing of the packaging to prevent damage to the single-dose vials.

II. Inspection and Assessment Before Use

1. Observe the Physical Characteristics of the Solution

(1) The normal solution should be a clear, green-yellow liquid, free from visible particles, turbidity, or precipitate.

(2) If the color is markedly abnormal (e.g., darker, brownish, or faded), or if flocculent material or crystals appear in the vial, the solution has become unstable and should be discarded.

2. Check Packaging Integrity

(1) Confirm that the aluminum foil pouch is intact and sealed, and that the single-dose vial has no cracks or damage.

(2) If the packaging is damaged or the cap is loose, there may be a risk of microbial contamination, and the product should not be used.

3. Verify Storage Time Limits

(1) The expiration date is printed on the carton and the aluminum foil pouch; expired products must not be used.

(2) Additionally, if the product has been exposed to temperatures exceeding recommended limits for a prolonged period (e.g., high temperature inside a car in summer), even if appearance appears normal, consult a pharmacist regarding whether it is still usable.

III. Handling After Opening and Disposal

1. Use Immediately and Discard; Do Not Store Remaining Solution

(1) Each single-dose vial is for single use only. After instilling both eyes, any remaining solution in the vial must be discarded immediately, regardless of the amount left.

(2) This product contains no preservatives. Once opened, sterility is no longer guaranteed. Any leftover solution must not be saved for future use, as this may lead to serious ocular infection.

2. Disposal Method

(1) Used empty vials and any remaining solution should be disposed of in household trash, out of reach of children and pets.

(2) Do not flush down the toilet or drain, to avoid environmental contamination.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Side effects and adverse reactions of tevinofop alfa (Avlayah)
During treatment with Tividnofusp alfa, various side effects may occur, involving hypersensitivity reactions, infusion-related reactions, hematologic abnormalities, and renal injury.I. Common Adverse ...
Storage of Tevinofop alfa (Avlayah)
Teverinofusp alfa is a lyophilized powder for injection. Its storage involves three different stages: unopened original packaging, after reconstitution, and after dilution. Each stage has strict requi...
Storage conditions for Navepegritide
Navepegritide, as a biologic macromolecular drug, has active ingredients sensitive to temperature, light, and time, requiring strict management across three levels: refrigerated storage, room temperat...
Dosage and Administration of Navepegritide
Mastering the dose calculation, preparation operation, injection technique, and missed-dose management for Navepegritide is the key to ensuring smooth treatment.I. Dose Determination and Adjustment Pr...
Precautions for Use of Carbachol and Brimonidine Tartrate Ophthalmic Solution (Yuvezzi)
Safe use of carbachol and brimonidine tartrate ophthalmic solution requires not only proper instillation but also comprehensive attention to visual changes, operational procedures, and systemic effect...
Indications and Contraindications of Copper Histidinate (Zycubo)
Histidine copper (Zycubo), as a copper replacement therapy, has a specific range of applicable diseases, and there are also clear contraindications. Accurately mastering this information helps to avoi...
Use in Special Populations of Copper Histidinate (Zycubo)
Copper histidinate (Zycubo) is primarily used for the treatment of rare pediatric diseases, but its safety and medication considerations differ significantly among populations with different physiolog...
Storage of Relicolan (Lifyorli)
Proper storage of Lifyorli  is the foundation for ensuring drug stability and therapeutic efficacy. The following instructions cover storage conditions, packaging management, and precautions duri...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved